Growth, Behavior, and Clinical Findings in 27 Patients with Kabuki (Niikawa-Kuroki) Syndrome
Overview
Authors
Affiliations
This study was undertaken to document the phenotype of Kabuki (Niikawa-Kuroki) syndrome in patients from Australia and New Zealand, with particular emphasis on growth patterns, behavior, and relationship between head circumference and intellectual level. Data on 27 children and adults with Kabuki (Niikawa-Kuroki) syndrome from Australia and New Zealand were collected by questionnaire and clinical assessment. The patients ranged in age from 7 months to 36 years with a mean age of 7 years and 2 months. The mean age at diagnosis was 3(5/6) years, but in most cases, the facial phenotype was evident from infancy. The minimum birth prevalence was calculated at 1 in 86,000. Three of our patients died. Parents reported a behavior phenotype characterized by an excellent long-term memory and avoidance of eye contact. No correlation was found between head circumference and severity of intellectual disability. Eight of 14 patients over the age of 5 years were overweight or obese. Six of these eight patients had failure to thrive in infancy. One patient developed insulin-dependent diabetes mellitus in adolescence. Some individuals with Kabuki (Niikawa-Kuroki) syndrome show a characteristic growth profile with failure to thrive in infancy progressing to obesity or overweight in middle childhood or adolescence. A behavior phenotype was noted which requires further investigation. Head size is not a predictor of degree of intellectual disability.
Kabuki and CHARGE syndromes: overlapping symptoms and diagnostic challenges.
Cerqueira B, Milhomem E, Matos A, Pietrobom I, Leprevost C, Heilberg I Einstein (Sao Paulo). 2025; 23:eRC1142.
PMID: 39969027 PMC: 11869784. DOI: 10.31744/einstein_journal/2025RC1142.
Incidence of hip problems in developmental central hypotonia: A scoping review.
Livingstone R, Paleg G, Shrader M, Miller F, Rodby-Bousquet E Dev Med Child Neurol. 2024; 67(3):307-321.
PMID: 39429029 PMC: 11794678. DOI: 10.1111/dmcn.16124.
Case report: Macrophage activation syndrome in a patient with Kabuki syndrome.
Zhang J, Kang Y, Xia Z, Chong Y, Long X, Shen M Front Immunol. 2024; 15:1412084.
PMID: 39139573 PMC: 11319294. DOI: 10.3389/fimmu.2024.1412084.
Clinical and molecular characteristics of Korean patients with Kabuki syndrome.
Yoon J, Hwang S, Bae H, Kim D, Seo G, Koh J J Hum Genet. 2024; 69(9):417-423.
PMID: 38824232 DOI: 10.1038/s10038-024-01258-1.
Next generation phenotyping for diagnosis and phenotype-genotype correlations in Kabuki syndrome.
Hennocq Q, Willems M, Amiel J, Arpin S, Attie-Bitach T, Bongibault T Sci Rep. 2024; 14(1):2330.
PMID: 38282012 PMC: 10822856. DOI: 10.1038/s41598-024-52691-3.